ArticleFrontiers in oncology2020

Recombinant KRAS G12D Protein Vaccines Elicit Significant Anti-Tumor Effects in Mouse CT26 Tumor Models.

Yuhua Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.